Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-27

Clinical Trial Update: Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the impact of albendazole and ivermectin on Wuchereria bancrofti in Mali has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)
  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Centre d'Appui à la lutte contre la Maladie | Conditions: Lymphatic Filariasis | Phase 4 | Status: COMPLETED